Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Heneka

Showing results (31-40 of 313) with videos related to

Pageof 32
Sort By:
Alzheimer'S Research & Therapy|March 6, 2017
Role of neuroinflammation in neurodegeneration: new insightsRóisín M McManus, Michael T Heneka
Molecular Neurodegeneration|April 2, 2024
The endotoxin hypothesis of Alzheimer's diseaseGuy C Brown, Michael T Heneka
Acta Neuropathologica|August 28, 2024
Inflammatory aspects of Alzheimer's diseasePablo Botella Lucena, Michael T Heneka
Immunity|April 10, 2024
Innate immune activation in neurodegenerative diseasesSergio Castro-Gomez, Michael T Heneka
Nature Reviews. Neurology|January 9, 2024
Inflammasomes in neurological disorders - mechanisms and therapeutic potentialKishore Aravind Ravichandran, Michael T Heneka
Biochimica Et Biophysica Acta|June 16, 2007
PPARs in the brainMichael T Heneka, Gary E Landreth
Alzheimer'S Research & Therapy|July 18, 2014
Truncated and modified amyloid-beta speciesMarkus P Kummer, Michael T Heneka
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2013
Studying M1 and M2 states in adult microgliaSadanand M Gaikwad, Michael T Heneka
Lancet (London, England)|November 16, 2024
Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challengesMichael T Heneka, David Morgan, Frank Jessen
Nature Metabolism|April 10, 2025
Incretin-based therapeutics for the treatment of neurodegenerative diseasesAnika Vear, Michael T Heneka, Christoffer Clemmensen
Pageof 32

Showing results (31-40 of 313) with videos related to

Sort By:
Pageof 32
Alzheimer'S Research & Therapy|March 6, 2017
Role of neuroinflammation in neurodegeneration: new insightsRóisín M McManus, Michael T Heneka
Molecular Neurodegeneration|April 2, 2024
The endotoxin hypothesis of Alzheimer's diseaseGuy C Brown, Michael T Heneka
Acta Neuropathologica|August 28, 2024
Inflammatory aspects of Alzheimer's diseasePablo Botella Lucena, Michael T Heneka
Immunity|April 10, 2024
Innate immune activation in neurodegenerative diseasesSergio Castro-Gomez, Michael T Heneka
Nature Reviews. Neurology|January 9, 2024
Inflammasomes in neurological disorders - mechanisms and therapeutic potentialKishore Aravind Ravichandran, Michael T Heneka
Biochimica Et Biophysica Acta|June 16, 2007
PPARs in the brainMichael T Heneka, Gary E Landreth
Alzheimer'S Research & Therapy|July 18, 2014
Truncated and modified amyloid-beta speciesMarkus P Kummer, Michael T Heneka
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2013
Studying M1 and M2 states in adult microgliaSadanand M Gaikwad, Michael T Heneka
Lancet (London, England)|November 16, 2024
Passive anti-amyloid β immunotherapy in Alzheimer's disease-opportunities and challengesMichael T Heneka, David Morgan, Frank Jessen
Nature Metabolism|April 10, 2025
Incretin-based therapeutics for the treatment of neurodegenerative diseasesAnika Vear, Michael T Heneka, Christoffer Clemmensen
Pageof 32